Parathyroid hormone regulates the distribution and osteoclastogenic potential of hematopoietic progenitors in the bone marrow

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Bone and Mineral Research

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jbmr.324PMID 21611963PMCID PMC3312755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunohistochemical identification of the PTHR1 parathyroid hormone receptor in normal and neoplastic human tissues.

  2010cited by this paper
• Alendronate reduces osteoclast precursors in osteoporosis

  2010cited by this paper
• Intermittent PTH Administration Stimulates Pre‐Osteoblastic Proliferation Without Leading to Enhanced Bone Formation in Osteoclast‐Less c‐fos−/− Mice

  2009cited by this paper
• Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts.

  2009cited by this paper
• Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche

  2009cited by this paper
• Prolonged Treatments With Antiresorptive Agents and PTH Have Different Effects on Bone Strength and the Degree of Mineralization in Old Estrogen-Deficient Osteoporotic Rats

  2008cited by this paper
• Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow.

  2008cited by this paper
• Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation.

  2008cited by this paper
• Osteoimmunology: interactions of the bone and immune system.

  2008cited by this paper
• Skeletal remodeling in health and disease

  2007cited by this paper
• The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization.

  2007cited by this paper
• Bisphosphonates: Mode of Action and Pharmacology

  2007cited by this paper
• Therapeutic targeting of a stem cell niche

  2007influential reference
• Determination of Dual Effects of Parathyroid Hormone on Skeletal Gene Expression in Vivo by Microarray and Network Analysis*

  2007cited by this paper
• Identification of Multiple Osteoclast Precursor Populations in Murine Bone Marrow

  2005cited by this paper
• Cells of the osteoclast lineage as mediators of the anabolic actions of parathyroid hormone in bone.

  2005cited by this paper
• Comparison of the Action of Transient and Continuous PTH on Primary Osteoblast Cultures Expressing Differentiation Stage‐Specific GFP

  2004cited by this paper
• Osteoblastic cells regulate the haematopoietic stem cell niche

  2003cited by this paper
• Identification of the haematopoietic stem cell niche and control of the niche size

  2003cited by this paper
• Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure.

  2003cited by this paper
• Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

  2001cited by this paper
• Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells

  2001cited by this paper
• Bone resorption by osteoclasts.

  2000influential reference
• Comparison of bone formation responses to parathyroid hormone(1-34), (1-31), and (2-34) in mice.

  2000cited by this paper
• Therapeutic approaches to bone diseases.

  2000cited by this paper
• Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.

  1999cited by this paper
• Physiology and pathophysiology of bone remodeling.

  1999influential reference
• Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice.

  1999cited by this paper
• Anabolic or Catabolic Responses of MC3T3‐E1 Osteoblastic Cells to Parathyroid Hormone Depend on Time and Duration of Treatment

  1999cited by this paper
• Induction of osteoclast formation by parathyroid hormone depends on an action on stromal cells.

  1998cited by this paper
• Nitrogen‐Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post‐Translational Prenylation of GTP‐Binding Proteins, Including Ras

  1998cited by this paper
• Effect of alendronate treatment on the osteoclastogenic potential of bone marrow cells in mice.

  1997cited by this paper
• Identification of clonogenic common lymphoid progenitors in mouse bone marrow.

  1997cited by this paper
• Searching for hematopoietic stem cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow

  1992cited by this paper
• A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide.

  1991cited by this paper
• Purification and characterization of mouse hematopoietic stem cells.

  1988cited by this paper
• Osteopetrosis cured by temporary parabiosis.

  1973influential reference
• A Comparison of

  1971cited by this paper
• Printed in U.S.A. Copyright © 1999 by The Endocrine Society Parathyroid Hormone Stimulates TRANCE and Inhibits Osteoprotegerin Messenger Ribonucleic Acid Expression in Murine Bone Marrow Cultures: Correlation with

  year unknowncited by this paper

• Impact of parathyroid Hormone’s dose, timing, and delivery mode on osteoclastogenesis and osteogenesis using a human periodontal ligament fibroblast model

  2025cites this paper
• Kerala Ayurveda Ostoact Tablet treats osteoporosis in ovariectomized rat model via regulating RANKL/OPG pathway

  2024cites this paper
• Aggressive Brown Tumors of the Maxilla and Mandible Post-Parathyroidectomy in Chronic Renal Failure: A Case Report and Literature Review

  2024cites this paper
• Reversing the imbalance in bone homeostasis via sustained release of SIRT-1 agonist to promote bone healing under osteoporotic condition

  2022cites this paper
• Inhibition of Notch Signaling Stimulates Osteoclastogenesis From the Common Trilineage Progenitor Under Inflammatory Conditions

  2022influential citation
• Novel population of human monocyte and osteoclast progenitors from pluripotent stem cells and peripheral blood

  2021cites this paper
• Effect of MC3T3 cell density on osteoclastic differentiation of mouse bone marrow cells.

  2021cites this paper
• Treatment secondary hyperparathyroidoidism in a patient receiving hemodialysis with combination therapy – paricalcitol and cinacalcet

  2020cites this paper
• Parathyroid Hormones

  2020cites this paper
• Endogenous parathyroid hormone (PTH) signals through osteoblasts via RANKL during fracture healing to affect osteoclasts.

  2020cites this paper
• Osteopetrosis

  2019cites this paper
• The Long Pentraxin 3 Plays a Role in Bone Turnover and Repair

  2018cites this paper
• Sex differences impact the lung-bone inflammatory response to repetitive inhalant lipopolysaccharide exposures in mice

  2018cites this paper
• Osteopetroses, emphasizing potential approaches to treatment.

  2017cites this paper
• An Antibody to Notch2 Reverses the Osteopenic Phenotype of Hajdu-Cheney Mutant Male Mice

  2017cites this paper
• Parathyroid hormone 1-34 and skeletal anabolic action

  2017cites this paper
• Modulación in Vitro de la Actividad Osteoclástica Mediada por Diferentes Dosis de Hormona Paratiroidea

  2017cites this paper
• The effects of spinal cord injury on bone loss and dysregulation of the calcium/parathyroid hormone loop in mice

  2016cites this paper
• FTY-720P Suppresses Osteoclast Formation by Regulating Expression of Interleukin-6 (IL-6), Interleukin-4 (IL-4), and Matrix Metalloproteinase 2 (MMP-2)

  2016cites this paper
• Parathyroid Hormone (1–34) Transiently Protects Against Radiation-Induced Bone Fragility

  2016cites this paper
• Modulação da atividade osteoclástica in vitro mediada por diferentes doses do hormônio da paratireóide

  2016cites this paper
• Toll-Like Receptor 4 Signaling Pathway Mediates Inhalant Organic Dust-Induced Bone Loss

  2016cites this paper
• Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-stimulated cAMP Signaling in Murine Osteoblasts*

  2015cites this paper
• Hajdu Cheney Mouse Mutants Exhibit Osteopenia, Increased Osteoclastogenesis, and Bone Resorption*♦

  2015cites this paper
• Continuous PTH: A Tale of Two Pathways

  2015cites this paper
• Efficacy and initial dose determination of paricalcitol for treatment of secondary hyperparathyroidism in Chinese subjects.

  2014cites this paper
• Altered Hematopoietic Stem Cell and Osteoclast Precursor Frequency in Cathepsin K Null Mice

  2014cites this paper
• Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation

  2014cites this paper
• Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis

  2014cites this paper
• Fragmented Adipose Tissue Transplanted to Craniofacial Deformities Induces Bone Repair Associated with Immunoexpression of Adiponectin and Parathyroid Hormone 1-Receptor

  2013cites this paper
• Effect of Zoledronate on the Responses of Osteocytes to Acute Parathyroid Hormone

  2013cites this paper
• Osteoprotegerin, RANKL, and Bone Turnover in Primary Hyperparathyroidism: The Effect of Parathyroidectomy and Treatment with Alendronate

  2013cites this paper
• PARICALCITOL COMPARED TO CINACALCET WITH LOW-DOSE VITAMIN D THERAPY FOR THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS RECEIVING HAEMODIALYSIS: RESULTS OF THE IMPACT SHPT RESEARCH

  2013cites this paper
• Therapeutic Effects of Cortex acanthopanacis Aqueous Extract on Bone Metabolism of Ovariectomized Rats

  2012cites this paper
• What We Learn from Bone Complications in Congenital Diseases? Thalassemia, an Example

  2012cites this paper
• INFLUÊNCIA DO PARASITISMO GASTROINTESTINAL NOS NÍVEIS DE CÁLCIO, FÓSFORO, MAGNÉSIO SÉRICOS E PROTEINOGRAMA DE CÃES NATURALMENTE INFECTADOS

  2012cites this paper
• Therapeutic effect of aqueous extract from Ecliptae herba on bone metabolism of ovariectomized rats

  2012cites this paper
• Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study

  2012cites this paper
• Proteoglycan 4, a novel immunomodulatory factor, regulates parathyroid hormone actions on hematopoietic cells.

  2011cites this paper
• Significance and regulation of CD68 expression in the osteoclast

  2011cites this paper
• The bone marrow at the crossroads of blood and immunity

  2011cites this paper